Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 3

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 3
---
-   (3,120)  -   (3,120)Other comprehensive loss  -   -   -   -   18   18 Balance, September 30, 2025  1,555  $2  $58,491  $(58,849) $(277) $(633)                                   Additional       Accumulated Other         Common Stock  Paid-in  Accumulated   Comprehensive        Shares  Amount  Capital  Deficit  Income (loss)  Total                          Balance, December 31, 2023  532  $1  $52,264  $(40,310) $(203) $11,752                          Common stock issued for cash  6   -   55   -   -   55 Stock based compensation  -   -   213   -   -   213 Net loss for the period  -   -   -   (2,483)  -   (2,483)Balance, March 31, 2024  538  $1  $52,532  $(42,793) $(203) $9,537                          Stock based compensation  -   -   195   -   -   195 Net loss for the period  -   -   -   (2,433)  -   (2,433)Balance, June 30, 2024  538  $1  $52,727  $(45,226) $(203) $7,299                          Stock based compensation  -   -   209   -   -   209 Net loss for the period  -   -   -   (1,132)  -   (1,132)Other comprehensive loss  -   -   -   -   (15)  (15)Balance, September 30, 2024  538  $1  $52,936  $(46,358) $(218) $6,361